Human Investing LLC Verastem, Inc. Transaction History

Human Investing LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 27, 2020	SELL	$1.11 - $1.68 $1,665 - $2,520	-1,500 Closed	0 $0
Q2 2020 Jul 22, 2020	BUY	$1.69 - $4.2 $2,535 - $6,300	1,500 New	1,500 $3,000
Q1 2020 Apr 22, 2020	SELL	$1.26 - $3.38 $3,780 - $10,140	-3,000 Closed	0 $0
Q4 2019 Feb 07, 2020	BUY	$0.86 - $1.44 $2,580 - $4,320	3,000 New	3,000 $4,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.25B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Human Investing LLC, based on Form 13F filings with the SEC.

Stay updated on Human Investing LLC with notifications on news.